- Home
- MS vs AZN Comparison
MS vs AZN Comparison
Compare MS & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MS
- AZN
- Stock Information
- Founded
- MS 1924
- AZN 1992
- Country
- MS United States
- AZN United Kingdom
- Employees
- MS N/A
- AZN N/A
- Industry
- MS Investment Bankers/Brokers/Service
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- MS Finance
- AZN Health Care
- Exchange
- MS Nasdaq
- AZN Nasdaq
- Market Cap
- MS 215.1B
- AZN 212.2B
- IPO Year
- MS N/A
- AZN 1993
- Fundamental
- Price
- MS $123.45
- AZN $65.35
- Analyst Decision
- MS Buy
- AZN Buy
- Analyst Count
- MS 16
- AZN 10
- Target Price
- MS $123.00
- AZN $88.80
- AVG Volume (30 Days)
- MS 6.7M
- AZN 5.6M
- Earning Date
- MS 01-16-2025
- AZN 02-06-2025
- Dividend Yield
- MS 3.00%
- AZN 2.27%
- EPS Growth
- MS 17.45
- AZN 9.79
- EPS
- MS 6.57
- AZN 4.15
- Revenue
- MS $58,282,000,000.00
- AZN $51,206,000,000.00
- Revenue This Year
- MS $15.18
- AZN $17.69
- Revenue Next Year
- MS $4.63
- AZN $7.95
- P/E Ratio
- MS $18.80
- AZN $30.78
- Revenue Growth
- MS 9.18
- AZN 13.81
- 52 Week Low
- MS $83.09
- AZN $60.47
- 52 Week High
- MS $136.24
- AZN $87.68
- Technical
- Relative Strength Index (RSI)
- MS 41.88
- AZN 41.89
- Support Level
- MS $120.29
- AZN $66.14
- Resistance Level
- MS $129.31
- AZN $67.47
- Average True Range (ATR)
- MS 2.75
- AZN 0.93
- MACD
- MS -1.33
- AZN -0.03
- Stochastic Oscillator
- MS 24.50
- AZN 30.45
About MS Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 30% of its total revenue is from outside the Americas. The company had over $5 trillion of client assets as well as around 80,000 employees at the end of 2023.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.